Metamizol Aristo (Metamizole Magnesium)

Metamizole magnesium inhibits cyclooxygenase enzymes, decreasing prostaglandin production, and also modulates central pain pathways. This dual action provides analgesic, antipyretic, and spasmolytic effects, although the precise molecular details are not fully defined.

The dosage of Metamizol Aristo is determined by the prescribing clinician based on the patient’s condition, age, weight, and renal or hepatic function. Only a qualified health professional should set the appropriate regimen.

Safety data for Metamizole magnesium in pregnancy and lactation are limited. It should be used only when the potential therapeutic benefit justifies the possible risk to the fetus or infant, and only under medical supervision.

To request Metamizol Aristo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with traditional NSAIDs, Metamizole magnesium offers analgesic and antipyretic effects with a lower incidence of gastrointestinal ulceration, but it carries a rare risk of agranulocytosis. Clinicians weigh these differences when selecting therapy for individual patients.

Metamizol Aristo should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and sources of heat to maintain stability.

Metamizol Aristo is taken orally, usually as a tablet or oral solution, and should be swallowed with water. The exact administration instructions, including timing relative to meals, are provided by the prescribing physician.

The most serious adverse reactions include agranulocytosis, a potentially life‑threatening drop in white‑blood‑cell count, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical care if they develop signs of infection, fever, or allergic symptoms.

Metamizol Aristo is contraindicated in individuals with a known hypersensitivity to metamizole or other pyrazolones, in patients with a history of agranulocytosis, and in those with severe hepatic or renal impairment unless specifically directed by a physician.